• No results found

[PDF] Top 20 Formulation and in vitro evaluation of modified release Gliclazide tablet

Has 10000 "Formulation and in vitro evaluation of modified release Gliclazide tablet" found on our website. Below are the top 20 most common "Formulation and in vitro evaluation of modified release Gliclazide tablet".

Formulation and in vitro evaluation of modified release Gliclazide tablet

Formulation and in vitro evaluation of modified release Gliclazide tablet

... All ingredients were accurately weighed. Gliclazide, polyvinylpyrrolidone and dibasic calcium hydrogen phosphate dihydrate were sifted through a suitable mesh to obtain a blend. The blend of step 2 was transferred ... See full document

5

In vitro evaluation of modified release formulations of nifedipine from Indian market

In vitro evaluation of modified release formulations of nifedipine from Indian market

... (NIPER formulation) and was comparable to that of reference product (Cardules retard manufactured by Nicholas Piramal ...in vitro evaluation of marketed nifedipine modified release ... See full document

6

FORMULATION AND IN VITRO EVALUATION OF SUSTAINED RELEASE MATRIX TABLET OF DICYCLOMINE HYDROCHLORIDE BY USING HYDROPHILIC POLYMERS

FORMULATION AND IN VITRO EVALUATION OF SUSTAINED RELEASE MATRIX TABLET OF DICYCLOMINE HYDROCHLORIDE BY USING HYDROPHILIC POLYMERS

... Post-compression parameters: The physical properties of different batches of matrix tablet are given in Table 3. The mean thickness of all the formulations was almost uniform and the values ranged from 3.23 ± 0.01 ... See full document

8

FORMULATION AND IN-VITRO EVALUATION OF SUSTAINED RELEASE MATRIX TABLETS OF LEVOFLOXACIN

FORMULATION AND IN-VITRO EVALUATION OF SUSTAINED RELEASE MATRIX TABLETS OF LEVOFLOXACIN

... drug release from the matrix system, the in vitro release rate were fitted to Korsmeyer-peppas model and interpretation of release exponent value (n) enlighten in understanding the ... See full document

9

FORMULATION DEVELOPMENT AND IN VITRO EVALUATION OF PULSATILE RELEASE TABLET OF BUDESONIDE

FORMULATION DEVELOPMENT AND IN VITRO EVALUATION OF PULSATILE RELEASE TABLET OF BUDESONIDE

... www.wjpr.net Vol 4, Issue 1, 2015. 1199 Budesonide were selected as model standard drugs to treat IBD. Budesonide is a potent, synthetic non-halogenated corticosteroid with high topical anti-inflammatory effect and ... See full document

12

FORMULATION AND IN VITRO EVALUATION OF BUPROPION HYDROCHLORIDE CONTROLLED RELEASE TABLET

FORMULATION AND IN VITRO EVALUATION OF BUPROPION HYDROCHLORIDE CONTROLLED RELEASE TABLET

... controlled release refers to the continuous release of their active ingredients at predetermined rate and predetermined ...Controlled release drug therapy reduces the dosing frequency, eliminates ... See full document

8

FORMULATION AND IN VITRO EVALUATION OF BILAYER TABLET OF ATENOLOL FOR BIPHASIC DRUG RELEASE

FORMULATION AND IN VITRO EVALUATION OF BILAYER TABLET OF ATENOLOL FOR BIPHASIC DRUG RELEASE

... immediate release layer had the pink color, and the sustained release layer has white color different formulations were made to achieve the desired drug release from the IR layer and SR layer of the ... See full document

6

FORMULATION, OPTIMIZATION AND IN VITRO EVALUATION OF DICLOFENAC SODIUM LOADED SUSTAINED RELEASE MATRIX TABLET CONTAINING BOTH NATURAL AND SEMI SYNTHETIC POLYMERS

FORMULATION, OPTIMIZATION AND IN VITRO EVALUATION OF DICLOFENAC SODIUM LOADED SUSTAINED RELEASE MATRIX TABLET CONTAINING BOTH NATURAL AND SEMI SYNTHETIC POLYMERS

... the release rates of matrix tablet loaded with diclofenac ...the tablet was completed by taking quantity of Guar gum and HPMC K4M in percentage as self-governing variable and cumulative percent of ... See full document

7

Formulation and In-Vitro Evaluation of Sustained Release Matrix Tablets of Gliclazide

Formulation and In-Vitro Evaluation of Sustained Release Matrix Tablets of Gliclazide

... Oral route has been the commonly adopted and most convenient route for the drug delivery. Oral route of administration has been received more attention in the pharmaceutical field, because of the more flexibility in the ... See full document

144

FORMULATION AND IN VITRO EVALUATION OF SALBUTAMOL SULPHATE SUSTAINED RELEASE TABLET BY USING FLOATING DRUG DELIVERY TECHNOLOGY

FORMULATION AND IN VITRO EVALUATION OF SALBUTAMOL SULPHATE SUSTAINED RELEASE TABLET BY USING FLOATING DRUG DELIVERY TECHNOLOGY

... and evaluation of floating tablets of Salbutamol sulphate by direct compression method by using the hydrophilic polymer such as hydroxy propyl methyl cellulose (HPMC), Sodium carboxy methyl cellulose, Dextrin and ... See full document

7

FORMULATION, DEVELOPMENT AND IN VITRO EVALUATION OF IMMEDIATE RELEASE TABLET OF SITAGLIPTIN PHOSPHATE MONOHYDRATE

FORMULATION, DEVELOPMENT AND IN VITRO EVALUATION OF IMMEDIATE RELEASE TABLET OF SITAGLIPTIN PHOSPHATE MONOHYDRATE

... glucagon release from alpha cells and slow the absorption of nutrients into blood stream and further causes an increase in the amount of insulin release from beta ... See full document

13

Formulation and evaluation of combination porous tablet containing naproxen sodium as immediate release and sumatriptan  succinate as sustained release

Formulation and evaluation of combination porous tablet containing naproxen sodium as immediate release and sumatriptan succinate as sustained release

... conventional tablet. Therefore the object of present study was formulation development in vitro evaluation of porous combination tablet dosage form containing Naproxen sodium as ... See full document

11

FORMULATION DESIGN AND EVALUATION OF NON EFFERVACENT FLOATING TABLETS OF GLICLAZIDEMangulal KethavathDOWNLOAD/VIEW

FORMULATION DESIGN AND EVALUATION OF NON EFFERVACENT FLOATING TABLETS OF GLICLAZIDEMangulal KethavathDOWNLOAD/VIEW

... 9.Development of gastro retentive floating matrix tablets of diltiazem hydrochloride. R. Narayana Charyulu, Amit B. Patil, Lakshmi Deepika C.H, Prabhakar Prabhu, Shastry C.S. Nitte University J. H. Sci. Vol. 1, No. 1-3, ... See full document

8

DESIGN & INVITRO CHARACTERIZATION OF GLIBENCLAMIDE CONTROLLED RELEASE TABLETS

DESIGN & INVITRO CHARACTERIZATION OF GLIBENCLAMIDE CONTROLLED RELEASE TABLETS

... Shrestha, Formulation And In-Vitro Evaluation Of Controlled Release Tablet Of Bupropion Hydrochloride By Direct Compression Technique And Stability Study Ijpsr Vol 5 No 05 May ... See full document

18

Formulation and In Vitro Release Pattern Study of Gliclazide Matrix Tablet

Formulation and In Vitro Release Pattern Study of Gliclazide Matrix Tablet

... and modified release preparation are ...drug release profile and there is no evidence of bioavailability and bioequiva- lence study of such products in ...prepare modified release ... See full document

7

FORMULATION AND EVALUATION OF SUSTAINED RELEASE TABLET OF ACEBROPHYLLINE

FORMULATION AND EVALUATION OF SUSTAINED RELEASE TABLET OF ACEBROPHYLLINE

... matrix tablet was undertaken to produce a sustained-release dosage form of Acebrophylline, since this dosage forms is relatively simple and cheap to produce when compared to ...in vitro drug ... See full document

12

FORMULATION AND EVALUATION OF IMMEDIATE RELEASE TABLET OF VALSARTAN

FORMULATION AND EVALUATION OF IMMEDIATE RELEASE TABLET OF VALSARTAN

... immediate release tablet of valsartan by using combination of surfactants such as Poloxamer188, Sodium Lauryl Sulfate, Sodium stearate and other polymer such as Cross carmellose sodium, Avicel pH102, ... See full document

8

FORMULATION AND EVALUATION OF VILDAGLIPTIN IMMEDIATE RELEASE TABLET

FORMULATION AND EVALUATION OF VILDAGLIPTIN IMMEDIATE RELEASE TABLET

... a formulation of immediate release tablet of Vildagliptin close similar to marketed product by applying a simple manufacturing process such as direct ...immediate release tablet was ... See full document

13

Formulation and evaluation of atorvastatin calcium oral dispersible tablet

Formulation and evaluation of atorvastatin calcium oral dispersible tablet

... In vitro release studies were carried out using tablet dissolution test apparatus USP XXIII with paddle speed 75rpm using 900ml phosphate buffer ...drug release within 25 ...(99%) ... See full document

5

QBD-BASED DEVELOPMENT AND EVALUATION OF TIME-DEPENDENT CHRONOPHARMACEUTICAL DRUG DELIVERY SYSTEM OF AMOXICILLIN TRIHYDRATE FOR MANAGEMENT OF BACTERIAL INFECTION

QBD-BASED DEVELOPMENT AND EVALUATION OF TIME-DEPENDENT CHRONOPHARMACEUTICAL DRUG DELIVERY SYSTEM OF AMOXICILLIN TRIHYDRATE FOR MANAGEMENT OF BACTERIAL INFECTION

... delayed release granules were evaluated for hardness, thickness, friability, weight variation and drug ...in vitro drug release from different delayed release tablet formulations were ... See full document

13

Show all 10000 documents...